Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis ; volume:9 ; number:1 ; day:3 ; month:4 ; year:2019 ; pages:1-11 ; date:12.2019
Scientific reports ; 9, Heft 1 (3.4.2019), 1-11, 12.2019
- Urheber
-
Moik, Florian
Riedl, Jakob M.
Winder, Thomas
Terbuch, Angelika
Rossmann, Christopher H.
Szkandera, Joanna
Bauernhofer, Thomas
Kasparek, Anne-Katrin
Schaberl-Moser, Renate
Reicher, Andreas
Prinz, Felix
Pichler, Martin
Stöger, Herbert
Stotz, Michael
Gerger, Armin
Posch, Florian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-42069-1
- URN
-
urn:nbn:de:101:1-2019041921165389938283
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moik, Florian
- Riedl, Jakob M.
- Winder, Thomas
- Terbuch, Angelika
- Rossmann, Christopher H.
- Szkandera, Joanna
- Bauernhofer, Thomas
- Kasparek, Anne-Katrin
- Schaberl-Moser, Renate
- Reicher, Andreas
- Prinz, Felix
- Pichler, Martin
- Stöger, Herbert
- Stotz, Michael
- Gerger, Armin
- Posch, Florian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
Biliary tract radiology
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
Biliary tract and gallbladder cancer : a multidisciplinary approach
Biliary tract large cell neuroendocrine carcinoma: current evidence
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
Biliary tract radiology
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
Biliary tract and gallbladder cancer : a multidisciplinary approach
Biliary tract large cell neuroendocrine carcinoma: current evidence
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
Biliary tract radiology
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
Biliary tract and gallbladder cancer : a multidisciplinary approach